[go: up one dir, main page]

FR2862875B1 - PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES - Google Patents

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Info

Publication number
FR2862875B1
FR2862875B1 FR0314142A FR0314142A FR2862875B1 FR 2862875 B1 FR2862875 B1 FR 2862875B1 FR 0314142 A FR0314142 A FR 0314142A FR 0314142 A FR0314142 A FR 0314142A FR 2862875 B1 FR2862875 B1 FR 2862875B1
Authority
FR
France
Prior art keywords
acouphenes
treatment
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0314142A
Other languages
French (fr)
Other versions
FR2862875A1 (en
Inventor
Stephane Mathey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATHEY ACOUSTIQUE SERVICE
Original Assignee
MATHEY ACOUSTIQUE SERVICE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATHEY ACOUSTIQUE SERVICE filed Critical MATHEY ACOUSTIQUE SERVICE
Priority to FR0314142A priority Critical patent/FR2862875B1/en
Publication of FR2862875A1 publication Critical patent/FR2862875A1/en
Application granted granted Critical
Publication of FR2862875B1 publication Critical patent/FR2862875B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0314142A 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES Expired - Fee Related FR2862875B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0314142A FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0314142A FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Publications (2)

Publication Number Publication Date
FR2862875A1 FR2862875A1 (en) 2005-06-03
FR2862875B1 true FR2862875B1 (en) 2006-04-07

Family

ID=34566314

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0314142A Expired - Fee Related FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Country Status (1)

Country Link
FR (1) FR2862875B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010004644A1 (en) * 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
ES2253825T3 (en) * 1997-09-08 2006-06-01 Warner-Lambert Company Llc ANALGESIC COMPOSITIONS THAT INCLUDE ANTIEPILEPTIC COMPOUNDS AND PROCEDURES FOR USING THE SAME.
WO2000053225A1 (en) * 1999-03-10 2000-09-14 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
FR2862875A1 (en) 2005-06-03

Similar Documents

Publication Publication Date Title
FR13C0029I2 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
EP1501489A4 (en) POLYTHERAPY FOR THE TREATMENT OF CANCER
DE50206657D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
DE60239648D1 (en) Pharmaceutical compositions for the treatment of asthma
FR15C0046I2 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
MA27018A1 (en) PHARMACEUTICAL DOSAGE FORM OF AMORPHOUS NELFINAVIR MESYLATE.
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
EP1931691A4 (en) ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA
DE602004028763D1 (en) TE FOR THE TREATMENT OF VIRUS DISEASES
EP1601329A4 (en) AUTOMATED SYSTEM FOR THE TREATMENT OF INSOMNIA
IL175535A (en) Preparations for the treatment of neurodegenerative diseases
ATE384522T1 (en) MEDICATIONS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
ATE443704T1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISEASES
DE60204466D1 (en) INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
NO20055010D0 (en) Preparations containing lactulose for the treatment of potavirus infections
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
ATE522218T1 (en) DOSAGE UNIT CONTAINING PROSTAGLANDIN ANALOG FOR THE TREATMENT OF INTESTINAL CONSTITUTION
EP1749532A4 (en) MEDICAMENT FOR HEALING OR TREATMENT OF INJURY
DE60218375D1 (en) Pharmaceutical composition for the treatment of gynecological diseases
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
EP1750513A4 (en) USE OF GPCR54 LIGANDS FOR THE TREATMENT OF INFERTILITY
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
DE602004010172D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY FUNCTIONAL DISORDERS
EP1839653A4 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF SENSORY ANOMALY
FR2862875B1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070831